HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients
Open accessThe DOI matches its Crossref record.
Abstract
Human herpesvirus 6 (HHV-6) is detected in the plasma of approximately 40% of patients undergoing hematopoietic cell transplantation (HCT) and sporadically causes encephalitis in this population. The effect of HHV-6 reactivation on central nervous system function has not been fully characterized. This prospective study aimed to evaluate associations between HHV-6 reactivation and central nervous system dysfunction after allogeneic HCT. Patients were enrolled before HCT. Plasma samples were tested for HHV-6 at baseline and twice weekly after transplantation until day 84. Delirium was assessed at baseline, 3 times weekly until day 56, and weekly on days 56 to 84 using a validated instrument. Neurocognitive testing was performed at baseline and at approximately day 84. HHV-6 was detected in 111 (35%) of the 315 included patients. Patients with HHV-6 were more likely to develop delirium (adjusted odds ratio = 2.5; 95% confidence interval, 1.2-5.3) and demonstrate neurocognitive decline (adjusted odds ratio = 2.6; 95% confidence interval, 1.1-6.2) in the first 84 days after HCT. Cord blood and unrelated transplantation increased risk of HHV-6 reactivation. These data provide the basis to conduct a randomized clinical trial to determine whether prevention of HHV-6 reactivation will reduce neurocognitive morbidity in HCT recipients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Papadopoulou, A., Gerdemann, U., Katari, U. L., Tzannou, I., Liu, H., Martinez, C., Leung, K., Carrum, G., Gee, A. P., Vera, J. F., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008825 · Cited by 402
Chromosomally integrated human herpesvirus 6: questions and answers
Pellett, P. E., Ablashi, D. V., Ambros, P. F., Agut, H., Caserta, M. T., Descamps, V., Flamand, L., Gautheret‐Dejean, A., Hall, C. B., Kamble, R. T., et al. (2012) · Reviews in Medical Virology · doi:10.1002/rmv.715 · Cited by 377
“Symptoms and conditions that have been firmly associated with HHV-6B in immunocompromised patients include exanthematous rash, fever, seizures [7], encephalopathy [8], limbic encephalitis [9] and amnesia [10,11], cognitive dysfunction [12], lymphadenopathy [13], colitis [14–16], and hepatitis [17,18].”
BackgroundLaboratory and Clinical Aspects of Human Herpesvirus 6 Infections
Agut, H., Bonnafous, P., & Gautheret-Dejean, A. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00122-14 · Cited by 345
“Additional evidence for the direct effect of HHV-6 on the CNS came from a study which showed a strong correlation between HHV-6 reactivation and CNS dysfunction as measured by delirium and neurocognitive decline in HSCT patients (167).”
BackgroundUpdate on infections with human herpesviruses 6A, 6B, and 7
Agut, H., Bonnafous, P., & Gautheret-Dejean, A. (2017) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2016.09.004 · Cited by 96
Human Herpesviruses 6A, 6B, and 7
Agut, H., Bonnafous, P., & Gautheret-Dejean, A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0007-2015 · Cited by 87
Metadata
- Authors
- Zerr, D. M., Fann, J. R., Breiger, D., Boeckh, M., Adler, A. L., Xie, H., Delaney, C., Huang, M.-L., Corey, L., & Leisenring, W. M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2011-05-12
- Volume
- 117
- Issue
- 19
- Pages
- 5243-5249
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1985977631
- Cited by
- 138
- References
- 0
- FWCI
- 10.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. https://app.cochat.ai/papers/10.1182/blood-2010-10-316083
- The paper
- Zerr, D. M., Fann, J. R., Breiger, D., Boeckh, M., Adler, A. L., Xie, H., Delaney, C., Huang, M.-L., Corey, L., & Leisenring, W. M. (2011). HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. Blood. https://doi.org/10.1182/blood-2010-10-316083
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.